What is Vertex Pharmaceuticals's capex?

Vertex Pharmaceuticals (VRTX) reported capex of $109.40M in Q4 2025.

How has Vertex Pharmaceuticals's capex changed year-over-year?

Vertex Pharmaceuticals's capex increased by 47.0% year-over-year, from $74.43M to $109.40M.

What is the long-term trend for Vertex Pharmaceuticals's capex?

Over 2 years (2023 to 2025), Vertex Pharmaceuticals's capex has grown at a 47.8% compound annual growth rate (CAGR), from $200.40M to $437.60M.

What does capex mean?

Cash spent on purchasing or upgrading long-term physical assets.

Discontinued — last reported Q2 '16

Other

CapEx

Vertex Pharmaceuticals CapEx remained flat by 0.0% to $109.40M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 47.0%, from $74.43M to $109.40M. Over 2 years (FY 2023 to FY 2025), CapEx shows an upward trend with a 47.8% CAGR.

Analysis

StatementIncome Statement

SectionOther

CategoryCapital Allocation

SignalContext dependent

VolatilityModerate

First reportedQ1 2015

Last reportedQ2 2016

How to read this metric

High levels signal aggressive investment in future growth, while low levels may indicate a focus on cash preservation or asset-light strategy.

Detailed definition

Represents cash outflows for the acquisition or maintenance of long-term physical assets such as property, plants, and e...

Peer comparison

Standard metric for capital-intensive industries.

Metric ID: is_anet_capital_expenditures

Historical Data

3 years

	FY'23	FY'24	FY'25
Value	$200.40M	$297.70M	$437.60M
YoY Change	—	+48.6%	+47.0%

Range$200.40M – $437.60M

CAGR+47.8%

Avg YoY Growth+47.8%

Median YoY Growth+47.8%

Current Streak2+ years growth

Frequently Asked Questions

What is Vertex Pharmaceuticals's capex?: Vertex Pharmaceuticals (VRTX) reported capex of $109.40M in Q4 2025.
How has Vertex Pharmaceuticals's capex changed year-over-year?: Vertex Pharmaceuticals's capex increased by 47.0% year-over-year, from $74.43M to $109.40M.
What is the long-term trend for Vertex Pharmaceuticals's capex?: Over 2 years (2023 to 2025), Vertex Pharmaceuticals's capex has grown at a 47.8% compound annual growth rate (CAGR), from $200.40M to $437.60M.
What does capex mean?: Cash spent on purchasing or upgrading long-term physical assets.